Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.140
0.00 (0.00%)
Dec 16, 2025, 4:00 PM EST - Market closed
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $25.52 million as of December 16, 2025. Its market cap has decreased by -58.08% in one year.
Market Cap
25.52M
Enterprise Value
-42.29M
1-Year Change
-58.08%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $25.52M, a decrease of -92.83%. That is a compound annual growth rate of -78.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 25.52M | -60.54% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |